## MGM: MGM Resorts International - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 -0.1% below STRENGTH zone (4.0-10.0%); PEG 1.55 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($34.80)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 3, Bearish: 1)

**1. MGM Resorts Enters Long-term Branding Agreement in China**
- Source: Luxury Travel Advisor | 20251231T140841 | Bullish | Relevance: 100%
- MGM Resorts International has signed a new long-term branding agreement with MGM China Holdings Limited, effective January 1, 2026, extending through the current concession in 2032 and potentially until December 31, 2045. This agreement secures MGM China's brand usage rights and provides MGM Resorts with increased compensation, raising the monthly license fee from 1.75 percent to 3.5 percent of MGM China's adjusted consolidated net monthly revenues. The deal protects MGM China's shareholders by securing its key intangible asset and reflects MGM's significant market share gains since the pandemic.

**2. Jefferies: MGM CHINA (02282.HK) Licensing Fee Hike May Lead to 10% Drop in 2026 NP w/ Potential for Div. Policy Review**
- Source: AASTOCKS.com | 20251231T020838 | Somewhat-Bearish | Relevance: 100%
- Jefferies believes that MGM CHINA's new brand licensing agreement, which aligns with its gaming concession period, will result in a 6% decrease in its 2026 adjusted EBITDA and a 10% drop in net profit. This could necessitate a review of their dividend policy if they maintain a 50% payout ratio. Despite these projections, Jefferies maintains a 'Buy' rating with a target price of $19.

**3. Jefferies: MGM CHINA (02282.HK) Licensing Fee Hike May Lead to 10% Drop in 2026 NP w/ Potential for Div. Policy Review**
- Source: AASTOCKS.com | 20251231T020827 | Somewhat-Bearish | Relevance: 100%
- Jefferies predicts that MGM CHINA's new brand licensing agreement will cause a 6% decrease in its 2026 adjusted EBITDA and a 10% drop in net profit due to increased fees. This fee hike could also lead to a reduction in 2026/27 DPS if a 50% dividend payout ratio is maintained, prompting a potential review of the dividend policy. Jefferies maintains a Buy rating with a target price of $19.

**4. MGM Resorts and MGM China Sign Long-Term Branding Agreement**
- Source: Hotel News Resource | 20251229T180902 | Bullish | Relevance: 100%
- MGM Resorts International has signed a long-term branding agreement with MGM China Holdings Limited, effective January 1, 2026, allowing MGM China to use the "MGM" name through 2032 with possible extensions. This deal stabilizes MGM China's brand rights and eliminates annual renegotiations, while increasing the monthly license fee from 1.75% to 3.5% of MGM China's adjusted consolidated net monthly revenue for MGM Resorts. The agreement reflects MGM China's substantial market share growth post-pandemic and aims to enhance MGM Resorts' brand presence in key markets.

**5. MGM Resorts Extends Casino Branding Deal in Chinaâ€™s Macau Through License Term**
- Source: Casino.org | 20251229T163556 | Somewhat-Bullish | Relevance: 100%
- MGM Resorts International has extended its branding agreement with MGM China through 2032, coinciding with MGM China's gaming concession term in Macau. The new terms significantly increase the monthly licensing fee paid by MGM China to MGM Resorts from 1.75% to 3.5% of its adjusted consolidated net revenue, which analysts believe will negatively impact MGM China's near-term EBITDA. This extension aims to secure MGM China's brand usage and reflects the increased market share MGM China has achieved in Macau's gaming industry.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Barclays | $38 | $42 | -10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Barclays | down | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 13 ($39.88M) |
| Sells | 11 ($1.08M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Davis Selected Advis: 8.8% (+0.6%)
- Vanguard Group Inc: 8.6% (+1.5%)
- Blackrock Inc.: 5.3% (+6.6%)
- AQR Capital Manageme: 3.1% (+202.5%)
- Arrowstreet Capital,: 2.8% (+81.4%)

### Key Risks

1. Elevated short interest (13.2%): bears positioning against stock.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.55 elevated, pricing in significant growth expectations. Analyst sentiment negative (1 target cuts vs 0 raises). Insider buying signal ($39.9M), management confidence. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $10.0B |
| Beta | 1.48 |
| 52W Range | $25.30 - $41.32 |
| Short Interest | 13.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.55 |
| Forward P/E | 17.1 |
| Current P/E | 16.6 |
| YoY Growth | -2.8% |
| EPS Direction | FALLING |

### Technicals

MRS_20 weakening modestly (-0.9% over 5 days). Below STRENGTH zone by 4.1pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.07x) but short-term weakness (below SMA20). RSI neutral at 54. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.06% (CS: 47) | Neutral |
| RSI_14 | 53.9 | Neutral |
| MACD Histogram | -0.17 | Bearish |
| vs SMA20 | 0.994x | Below |
| vs SMA50 | 1.064x | Above |
| vs SMA200 | 1.073x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $36.48
- **Stop Loss:** $34.80 (4.6% risk)
- **Target:** $38.16 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 714
- **Position Value:** $26,046.72
- **Portfolio %:** 26.05%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with mixed signals requiring caution. VIX at 14.95 suggests calm markets, but record repo borrowing and narrowing breadth (51.4%) indicate stress beneath the surface. Positive yield curve (+62bps) and stable economic data support risk assets, but year-end dynamics mask true liquidity conditions.*

### Earnings

**Next:** 2026-02-11 (Est: $0.49)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.30 | $0.24 | -19.9% |
| 2025Q2 | $0.55 | $0.79 | +44.0% |
| 2025Q1 | $0.45 | $0.69 | +54.3% |
| 2024Q4 | $0.34 | $0.45 | +33.0% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*